08.12.2012 Views

Scientific Concept of the National Cohort (status ... - Nationale Kohorte

Scientific Concept of the National Cohort (status ... - Nationale Kohorte

Scientific Concept of the National Cohort (status ... - Nationale Kohorte

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

C.2<br />

C.2 Annex: Methods for Statistical Power and Sample Size Calculations<br />

C.2.3 Interaction effects between genetic and non-genetic (“environmen-<br />

N cases tal”) risk factors.<br />

10000<br />

9000<br />

In Sect. A.6.4.3 <strong>of</strong> <strong>the</strong> study protocol (main text), figure 6.5 shows <strong>the</strong> minimal detectable<br />

odds 8000ratio<br />

for gene-environment interaction (power 0.80, at significance level <strong>of</strong> 0.05), in a<br />

nested 7000 case-control study with N cases <strong>of</strong> disease, and control:case ratios <strong>of</strong> 4:1, at fixed<br />

(dominant) main effect odds ratios <strong>of</strong> 1.2 for <strong>the</strong> genetic variant, and a main effects odds<br />

6000<br />

ratio <strong>of</strong> 2.0 for <strong>the</strong> environmental factor.<br />

5000<br />

figure S6.2 below provides similar estimates, but at a significance level <strong>of</strong> 10-4 , which may<br />

4000<br />

be more appropriate when larger numbers <strong>of</strong> interactions are being tested simultaneously.<br />

This 3000 figure confirms that, for statistical interaction effects <strong>of</strong> moderate magnitude (MDOR<br />

for 2000 interaction around 1.5, a sample size <strong>of</strong> at least 4,000-5,000 cases <strong>of</strong> disease will be<br />

required for tests at this significance level. In <strong>the</strong> <strong>National</strong> <strong>Cohort</strong>, cumulative incidences<br />

1000<br />

<strong>of</strong> this magnitude will be reached only for <strong>the</strong> most common disease outcomes, including<br />

diabetes 0 and myocardial infarction.<br />

0.05 0.1 0.15 0.2 0.25 0.3 0.35 0.4 0.45 0.5<br />

figure S6.2: Study size (number <strong>of</strong> incident cases <strong>of</strong> disease) required to detect minimal odds<br />

ratios [MDOR] <strong>of</strong> various magnitudes, for gene-environment interaction with power 0.80, at significance<br />

level <strong>of</strong> 10-4 Allele frequency<br />

RGE 1.2 1.3 1.5 1.7 2 2.5<br />

*assuming ; nested main effects case-control odds ratios study <strong>of</strong> 1.2 with for genetic 4 controls and 2.0 for per non-genetic case*, assuming risk factor main effects<br />

odds ratios <strong>of</strong> 1.2 for <strong>the</strong> alpha=0.0001, genetic and prevalence 2.0 for <strong>the</strong> <strong>of</strong> non-genetic risk factor risk factor, 20% plus a prevalence <strong>of</strong> <strong>the</strong><br />

non-genetic risk factor <strong>of</strong> 0.20.<br />

N cases<br />

10000<br />

9000<br />

8000<br />

7000<br />

6000<br />

5000<br />

4000<br />

3000<br />

2000<br />

1000<br />

0<br />

0.05 0.1 0.15 0.2 0.25 0.3 0.35 0.4 0.45 0.5<br />

Allele frequency<br />

RGE 1.2 1.3 1.5 1.7 2 2.5<br />

*assuming main effects odds ratios <strong>of</strong> 1.2 for genetic and 2.0 for non-genetic risk factor<br />

alpha=0.0001, prevalence <strong>of</strong> non-genetic risk factor 20%<br />

280

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!